
Sign up to save your podcasts
Or


Stocks rose thanks to further US-China trade taxes being delayed.
Swiss drugmaker Roche announced a $5 billion acquisition of a gene therapy firm.
See acast.com/privacy for privacy and opt-out information.
By FinimizeStocks rose thanks to further US-China trade taxes being delayed.
Swiss drugmaker Roche announced a $5 billion acquisition of a gene therapy firm.
See acast.com/privacy for privacy and opt-out information.